搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
5 天
A Legacy in Liver Disease Treatments
As the largest internal organ in the human body, the liver supports a wide range of responsibilities related to metabolism, ...
7 天
Reverse Fatty Liver Naturally With 6 Drinks That Boost Liver Health
When there’s too much fat buildup in the liver—which filters toxins and aids digestion—it can get bogged down and trigger ...
Indiatimes
1 天
Fatty liver disease a fast-growing silent epidemic
The diagnosis —Crohn’s disease, which results in chronic inflammation of the digestive tract — further changed everything. The once 55-kg mother gained 10kg as treatment included steroids. “As I ...
Science Daily
11 天
Microbiome changes in chronic liver disease highlight the need for personalized treatment
People with chronic liver disease have dramatic changes to the types and functions of bacteria in the gut and mouth, a new study has revealed.
39健康 on MSN
1 天
脂肪肝不可怕,日常饮食可逆转!医生:多吃这些食物,效果看得见
瘦子也会得脂肪肝?查出脂肪肝怎么办?减少脂肪肝,一定要科学饮食。
Rolling Out
11 天
What to know about liver cancer symptoms
Liver cancer presents unique challenges for early detection, as initial symptoms often appear subtle or mimic common ailments ...
Indiatimes on MSN
2 天
The link between non-alcoholic fatty liver disease (NAFLD) and cardiovascular disease: What ...
The association between NAFLD and cardiovascular disease is not just coincidental. Several mechanisms contribute to this link ...
News Medical on MSN
5 小时
Breakthrough obesity treatment: A micro cure for a big problem
University of South Australia researchers have created a new, food-grade, natural solution for obesity, that not only cuts ...
News Medical
3 天
Targeted therapy induces regression in colorectal liver metastases
Explore how E-selectin-targeted polymer-doxorubicin therapy induces regression in colorectal liver metastases.
FierceBiotech
12 天
Viking pads case for MASH drug with final ph. 2 data showing significant reductions in ...
Viking Therapeutics has unveiled the final results of its phase 2b VOYAGE trial of oral small molecule VK2809 in metabolic ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈